H. Lundbeck AS (FRA:LDBB) Beginning Cash Position : €1,116 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Beginning Cash Position?

H. Lundbeck AS's Beginning Cash Position for the quarter that ended in Dec. 2024 was €1,116 Mil.

H. Lundbeck AS's quarterly Beginning Cash Position increased from Jun. 2024 (€685 Mil) to Sep. 2024 (€825 Mil) and increased from Sep. 2024 (€825 Mil) to Dec. 2024 (€1,116 Mil).

H. Lundbeck AS's annual Beginning Cash Position increased from Dec. 2022 (€306 Mil) to Dec. 2023 (€476 Mil) and increased from Dec. 2023 (€476 Mil) to Dec. 2024 (€672 Mil).

H. Lundbeck AS Beginning Cash Position Historical Data

The historical data trend for H. Lundbeck AS's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Beginning Cash Position Chart

H. Lundbeck AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

404.32

527.69

306.34

476.02

671.79

H. Lundbeck AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															569.94	671.91	685.07	825.22	1,115.89

H. Lundbeck AS Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

H. Lundbeck AS Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (FRA:LDBB) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

HLBBF:USA HLUBF:USA 0ABR:UK 0ND5:UK HLUN A:Denmark HLUN B:Denmark LUNB:Austria LUNA:Austria

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS Headlines

No Headlines